NO20043698L - Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life - Google Patents

Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life

Info

Publication number
NO20043698L
NO20043698L NO20043698A NO20043698A NO20043698L NO 20043698 L NO20043698 L NO 20043698L NO 20043698 A NO20043698 A NO 20043698A NO 20043698 A NO20043698 A NO 20043698A NO 20043698 L NO20043698 L NO 20043698L
Authority
NO
Norway
Prior art keywords
age
organs
heart failure
sodium hydrogen
ace inhibitors
Prior art date
Application number
NO20043698A
Other languages
Norwegian (no)
Inventor
Wolfgang Linz
Ursula Schindler
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20043698L publication Critical patent/NO20043698L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20043698A 2002-02-04 2004-08-31 Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life NO20043698L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10204571 2002-02-04
PCT/EP2003/000587 WO2003066045A1 (en) 2002-02-04 2003-01-22 Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan

Publications (1)

Publication Number Publication Date
NO20043698L true NO20043698L (en) 2004-08-31

Family

ID=27674558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043698A NO20043698L (en) 2002-02-04 2004-08-31 Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life

Country Status (23)

Country Link
EP (1) EP1474134B1 (en)
JP (1) JP4733348B2 (en)
KR (1) KR20040083498A (en)
CN (1) CN1319528C (en)
AR (1) AR038387A1 (en)
AT (1) ATE520398T1 (en)
AU (1) AU2003244430A1 (en)
BR (1) BR0307443A (en)
CA (1) CA2474888A1 (en)
CO (1) CO5601009A2 (en)
HR (1) HRP20040702A2 (en)
HU (1) HUP0402593A2 (en)
MA (1) MA27170A1 (en)
MX (1) MXPA04007569A (en)
NO (1) NO20043698L (en)
NZ (1) NZ534479A (en)
PE (1) PE20040188A1 (en)
PL (1) PL370488A1 (en)
RS (1) RS68204A (en)
RU (1) RU2004126702A (en)
TW (1) TW200306850A (en)
WO (1) WO2003066045A1 (en)
ZA (1) ZA200406066B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2795053A1 (en) * 2010-03-31 2011-10-06 The Hospital For Sick Children Use of remote ischemic conditioning to improve outcome after myocardial infarction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0855392A3 (en) * 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Five-membered heterocycles having biphenylsulphonyl substituents, processes for the preparation thereof, their use as medicaments or diagnostic agent and medicaments containing them
DE19734693A1 (en) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Use of cariporide to treat cardiac and non-cardiac disease
DE19737224A1 (en) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmaceutical preparation for cardiovascular treatment
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
DE19859727A1 (en) * 1998-12-23 2000-06-29 Aventis Pharma Gmbh The use of inhibitors of the sodium-hydrogen exchanger for the manufacture of a medicament for the prevention of age-related organ dysfunctions, age-related illnesses for the prolongation of life

Also Published As

Publication number Publication date
RS68204A (en) 2007-02-05
BR0307443A (en) 2005-01-04
WO2003066045A1 (en) 2003-08-14
PE20040188A1 (en) 2004-05-17
CA2474888A1 (en) 2003-08-14
ATE520398T1 (en) 2011-09-15
HUP0402593A2 (en) 2005-04-28
PL370488A1 (en) 2005-05-30
KR20040083498A (en) 2004-10-02
JP2005519072A (en) 2005-06-30
CO5601009A2 (en) 2006-01-31
ZA200406066B (en) 2005-06-08
CN1694697A (en) 2005-11-09
JP4733348B2 (en) 2011-07-27
EP1474134B1 (en) 2011-08-17
NZ534479A (en) 2006-03-31
AR038387A1 (en) 2005-01-12
RU2004126702A (en) 2005-04-20
TW200306850A (en) 2003-12-01
MA27170A1 (en) 2005-01-03
CN1319528C (en) 2007-06-06
EP1474134A1 (en) 2004-11-10
MXPA04007569A (en) 2004-11-01
AU2003244430A1 (en) 2003-09-02
HRP20040702A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
EA200800006A1 (en) TRIAZOLOPIRIDIN AS AN INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE I
EA200870091A1 (en) APPLICATION OF BENZO-CONDENSED HETEROCYCLIC SULFAMIDE DERIVATIVES FOR REMOVAL OF PAIN
NO20044617L (en) Substituted benzazoles and their use as RAF kinase inhibitors
MXJL06000006A (en) Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases.
MEP13008A (en) C-aryl glucoside sglt2 inhibitors and method
NO20033742D0 (en) Omega-aminoalkylamides of R-2-arylpropionic acids as inhibitors of polymophonuclear and mononuclear cells chemotaxis
NO20070247L (en) Amino-5,5-diphenylimidazolone derivatives for inhibition of beta-secretase
NO20044763L (en) 1- (aminoalkyl) -3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
DK1753748T3 (en) Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
DK1224183T3 (en) Heterocyclic sodium / proton exchange inhibitors and process
RS52601B (en) Benzothiazepine derivatives as ryanodine receptor (ryr2) inhibitors and their use in the treatment of cardiac diseases
DE50310980D1 (en) USE OF I kappa B-KINASE INHIBITORS IN PAIN THERAPY
EA200802223A1 (en) 1,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS
NO20051892L (en) New connection
WO2007109251A3 (en) Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
NO20064811L (en) 4- (5-Aminomethyl-2-fluoro-phenyl) -piperidin-1-yl] - (4-bromo-3-methyl-5-propoxy-thiophen-2-yl) -methanone hydrochloride as an inhibitor of mast cell tryptase
WO2004037796A3 (en) 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
NO20061821L (en) Amidomethyl-substituted 1- (carboxyalkyl) -cyclopentylcarbonylaminobenzazepine-N-acetic acid derivatives, processes and intermediates for their preparation, and drugs containing these compounds
NO20075662L (en) Roflumilast for the treatment of pulmonary hypertension
NO20070250L (en) S-Tenatoprazole sodium monohydrate salt and its use in the form of a proton pump inhibitor
NO20043698L (en) Combination preparation of the sodium hydrogen exchange inhibitor cariporide with ACE inhibitors for heart failure prevention and other age-related dysfunctions in organs, age-related diseases and for extended life
NO20013145L (en) Use of inhibitors of the sodium hydrogen exchanger for the preparation of a drug for the prevention of organ dysfunction and diseases related to a particular age and for a prolonged life
DK1505871T3 (en) Conservation of RNA and Morphology in Cells and Tissues
DE60305053D1 (en) Pyrimidine derivatives as selective COX-2 inhibitors
ATE257384T1 (en) USE OF CILOBRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS TO TREAT OR PREVENT HEART FAILURE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application